Anti-ageing compounds

Anti-ageing compounds has been studied in 2 papers since 2024: none in people yet, 1 in animals; 1 in the past year. The research so far is in animals. The newest paper, May 18, 2026: “AI-Accelerated Discovery of Novel Gero-suppressive Compounds: Quantifying the Enhancement of the Human Health span-To-Lifespan Ratio”.

Intervention

2 papers study it4 findingsUpdated

See all 2 papers on anti-ageing compounds

At a glance

The findings reach cells, none yet in people. 1 lab in 1 country.

Cells: a single group. Worms or flies, mice and humans: nothing yet.
  • 1 lab in 1 country
  • Funders: Biotechnology and Biological Sciences Research Council and 8 more
  • Model organisms1
  • In silico1

What did studies of anti-ageing compounds find?

3

Studies of anti-ageing compounds measured 3 outcomes: cellular senescence, healthspan and oxidative stress and ROS signaling.

Cellular senescence

downin human cells1downin silico1

2 studies
  1. Anti-ageing compounds inhibit cellular senescence in silico (computational prediction / screening).

    “The selected molecules showed considerable decreases in oxidative stress, inflammation, and cellular senescence markers”

    In silicocomputational prediction / screening

    AI-Accelerated Discovery of Novel Gero-suppressive Compounds: Quantifying the Enhancement of the Human Health span-To-Lifespan Ratio

    Journal of Pharmaceutical Research and Integrated Medical Sciences

  2. Anti-ageing compounds decrease cellular senescence in human primary cells with delayed epigenetic ageing.

    “delayed epigenetic ageing in human primary cells treated with anti-ageing compounds is accompanied by a reduction in senescence and ageing biomarkers”

    Cellsin human primary cells with delayed epigenetic ageing

    An expedited screening platform for the discovery of anti-ageing compounds in vitro and in vivo

    Genome medicine

More on Cellular senescence

Healthspan

upin silico1

1 study
  1. Anti-ageing compounds improve healthspan in silico (computational prediction / screening).

    “quantitative results showed that the use of AI for predicting the efficacy of anti-aging agents led to more significant healthspan enhancements than lifespan increases”

    In silicocomputational prediction / screening

    AI-Accelerated Discovery of Novel Gero-suppressive Compounds: Quantifying the Enhancement of the Human Health span-To-Lifespan Ratio

    Journal of Pharmaceutical Research and Integrated Medical Sciences

Oxidative stress and ROS signaling

downin silico1

1 study
  1. Anti-ageing compounds decrease oxidative stress and ROS signaling in silico (computational prediction / screening).

    “The selected molecules showed considerable decreases in oxidative stress, inflammation, and cellular senescence markers”

    In silicocomputational prediction / screening

    AI-Accelerated Discovery of Novel Gero-suppressive Compounds: Quantifying the Enhancement of the Human Health span-To-Lifespan Ratio

    Journal of Pharmaceutical Research and Integrated Medical Sciences

More on Oxidative stress and ROS signaling

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 1Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months